LENZ Therapeutics annual capital expenditures (capex)
2020
2021
2022
2023
2024
2025
LENZ Therapeutics Capital Expenditures (CapEx) Growth & History (LENZ)
LENZ Therapeutics's capital expenditures (capex) was $827,000 for fiscal 2025.
View full LENZ Therapeutics company overviewLENZ Therapeutics annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $827,000 | $359,000 | +76.71% |
| 2024 | 2024-12-31 | $468,000 | −$10.4M | −95.69% |
| 2023 | 2023-12-31 | $10.9M | $4.3M | +64.63% |
| 2022 | 2022-12-31 | $6.6M | $854,000 | +14.88% |
| 2021 | 2021-12-31 | $5.7M | $4.2M | +271.52% |
| 2020 | 2020-12-31 | $1.5M | — | — |
LENZ Therapeutics quarterly capital expenditures (capex)
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $16,000 | −$224,000 | −93.33% |
| Q1 2026 | 2026-03-31 | $18,000 | −$92,000 | −83.64% |
| Q4 2025 | 2025-12-31 | $38,000 | −$111,000 | −74.50% |
| Q3 2025 | 2025-09-30 | $439,000 | $253,000 | +136.02% |
| Q2 2025 | 2025-06-30 | $240,000 | $107,000 | +80.45% |
| Q1 2025 | 2025-03-31 | $110,000 | $110,000 | — |
| Q4 2024 | 2024-12-31 | $149,000 | −$10.7M | −98.62% |
| Q3 2024 | 2024-09-30 | $186,000 | −$5.8M | −96.88% |
| Q2 2024 | 2024-06-30 | $133,000 | −$5.9M | −97.78% |
| Q1 2024 | 2024-03-31 | $0 | −$6,000 | — |
| Q4 2023 | 2023-12-31 | $10.8M | $9.8M | +960.33% |
| Q3 2023 | 2023-09-30 | $6.0M | $5.0M | +551.69% |
| Q2 2023 | 2023-06-30 | $6.0M | $4.6M | +332.27% |
| Q1 2023 | 2023-03-31 | $6,000 | −$3.3M | −99.82% |
| Q4 2022 | 2022-12-31 | $1.0M | $40,000 | +4.08% |
| Q3 2022 | 2022-09-30 | $915,000 | −$2.7M | −74.83% |
| Q2 2022 | 2022-06-30 | $1.4M | $622,000 | +81.52% |
| Q1 2022 | 2022-03-31 | $3.3M | $2.9M | +809.17% |
| Q4 2021 | 2021-12-31 | $981,000 | — | — |
| Q3 2021 | 2021-09-30 | $3.6M | $3.1M | +556.32% |
| Q2 2021 | 2021-06-30 | $763,000 | — | — |
| Q1 2021 | 2021-03-31 | $360,000 | — | — |
| Q3 2020 | 2020-09-30 | $554,000 | — | — |
LENZ Therapeutics capital expenditures (capex) trends
Over the last five fiscal years, LENZ Therapeutics's capital expenditures (capex) decreased from $1.5M to $827,000, a change of −$718,000. The latest reported quarter, Q2 2026, shows $16,000.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review LENZ Therapeutics source filings ↗